A large fraction of CNS-PNETs can be re-classified into other CNS tumor entities
Four new CNS tumor entities emerge from the remaining fraction of CNS-PNETs
Each new entity is associated with distinct histological and clinical features
Each new entity is characterized by a defining recurrent genetic alteration